HER-2/neu overexpression in breast cancer

HER-2/neu overexpression in breast cancer

Background: In breast carcinoma, amplification &/or over-expression of HER-2/neu has been associated with a group of unfavorable prognostic factors. The Food & Drug Administration Agency approved Trastuzumab (Herceptin) for the therapy of metastatic breast cancer but only in patients with am...

Full description

Bibliographic Details
Main Authors:	Rana S. Aziz, Nabeel W. Rasheed
Format:	Article
Language:	English
Published:	College of Medicine University of Baghdad 2010-10-01
Series:	مجلة كلية الطب
Subjects:	HER-2/neu, breast carcinoma, prognostic variables
Online Access:	http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/977

Similar Items

CORRELATION OF HORMONAL RECEPTOR AND Her-2/neu EXPRESSION IN BREAST CANCER: A STUDY AT TERTIARY CARE HOSPITAL IN SOUTH GUJARAT
by: Vasudha M Bhagat, et al.
Published: (2012-09-01)

Role of p53 and Her2/Neu as a prognostic biomarker in breast carcinoma
by: Anamika Gupta, et al.
Published: (2023-01-01)

NEW INDICATORS OF HSP27 FUNCTIONAL STATE IN BREAST CANCER CELLS WITH DIFFERENT VARIANTS OF HER2/NEU-STATUS
by: E. V. Kaigorodova, et al.
Published: (2016-02-01)

The Study of HER-2/neu, ER/PR Expression Using Immunohistochemistry (IHC) in the Iraqi Breast Cancer
by: Suhad Faisal Hatem, et al.
Published: (2016-06-01)

Factors Influencing Lymph Node Positivity in HER2/neu+ Breast Cancer Patients
by: Katherine Englander, et al.
Published: (2023-02-01)

Breast Cancer in Kirkuk City, Hormone Receptors Status (Estrogen and Progesterone) and Her-2/Neu and Their Correlation with Other Pathologic Prognostic Variables
by: Mahmoud Mohammed Mahmoud
Published: (2019-11-01)

Breast Cancer in Kirkuk City, Hormone Receptors Status (Estrogen and Progesterone) and Her-2/Neu and Their Correlation with Other Pathologic Prognostic Variables
by: Mahmoud Mohammed Mahmoud
Published: (2019-11-01)

Quartz Crystal Microbalance (QCM) Based Biosensor Functionalized by HER2/neu Antibody for Breast Cancer Cell Detection
by: Merve Yılmaz, et al.
Published: (2021-04-01)

Comparative evaluation of the prognostic significance of molecular tumor markers (estrogen and progesterone receptors, HER-2/neu) and the Nottingham prognostic index in breast cancer
by: V. Sekhri, et al.
Published: (2024-02-01)

EGFR and HER2neu Expression in Gall Bladder Carcinoma and Its Association with Clinicopathological Parameters - An Institutional Experience from North India
by: Inara Abeer, et al.
Published: (2021-03-01)

Correlation of P53 Expression with Clinicopathological Parameters, Hormone Receptors and HER 2 Neu Status in Breast Carcinoma
by: Tahmida Ali, et al.
Published: (2022-11-01)

CORRELATION OF ESTROGEN RECEPTOR(ER), PROGESTERONE RECEPTOR(PR) AND HER2/NEU EXPRESSION WITH CLINICOPATHOLOGICAL PARAMETERS IN PRIMARY BREAST CARCINOMA -A STUDY OF 175 CASES
by: Hiral Samir Shah, et al.
Published: (2020-06-01)

Evaluation of the Her-2/neu value in papillary thyroid carcinoma and its relation to histopathological prognostic findings
by: Amin Azarnoosh, et al.
Published: (2024-01-01)

Association between HER-2/Neu overexpression in gastric adenocarcinoma and histopathologic features of tumor in gastrectomy samples: a cross-sectional study in Kerman, Iran
by: Mohammad Mahdi Hayatbakhsh Abbasi, et al.
Published: (2019-05-01)

A PROSPECTIVESTUDY OF ESTROGEN, PROGESTRONE AND HER2NEU RECEPTOR IN CASES OF BREAST CANCER IN A TERTIARY CARE HOSPITAL OF BHAVNAGAR, GUJARAT, WESTERN INDIA
by: Hathila Tejas N, et al.
Published: (2015-09-01)

A Comparative Study on HER2/neu Expression in Normal Mucosa, Epithelial Dysplasia and Oral Squamous Cell Carcinoma
by: Safoura Seifi, et al.
Published: (2010-01-01)

Clinicopathological Significance and Prognostic Role of Her2neu Protein Expression in Patients with Carcinoma Stomach: A Prospective Study from Northern India
by: Abhilash V. B., et al.
Published: (2023-04-01)

EVALUATION OF EXTENT OF BREAST CANCER IN A PATIENT WITH HER2/NEU OVEREXPRESSION USING A RADIOPHARMACEUTICAL BASED ON TECHNETIUM-99M-LABELED TARGET MOLECULES (CASE REPORT)
by: O. D. Bragina, et al.
Published: (2021-10-01)

Association of hTERT expression, Her2Neu, estrogen receptors, progesterone receptors, with telomere length before and at the end of treatment in breast cancer patients
by: Blanca Olivia Murillo-Ortiz, et al.
Published: (2024-08-01)

Anti-HER2/neu Antibody Reduces Chemotherapy-Induced Ovarian Toxicity—From Bench to Bedside
by: Mattan Levi, et al.
Published: (2020-12-01)

A study on molecular subtype of breast carcinoma using ER, HER2, PR, and its relation with Ki67
by: Haricharan BV, et al.
Published: (2023-11-01)

Associations between body mass index and hormonal receptor, HER2/neu receptor, as well as other clinical characteristics of breast cancer
by: Ahmed Qassim Hadi, et al.
Published: (2024-06-01)

Study of gastrointestinal neoplasms, histopathologic and immunohistochemical correlation using HER-2/NEU, CK-7 and CK-20
by: Pramod Kumar Reddy M, et al.
Published: (2023-07-01)

<i>HER2/neu</i> Oncogene Silencing in a Breast Cancer Cell Model Using Cationic Lipid-Based Delivery Systems
by: Adhika Balgobind, et al.
Published: (2023-04-01)

Immunomorphological specifcity of HER2-low breast cancer
by: I. V. Mikhailov, et al.
Published: (2024-11-01)

Expression And Scoring Of HER2/Neu in Variants of Prostate Adenocarcinoma
by: Santosh Kumar Sidhwani, et al.
Published: (2021-03-01)

Expression of Her2-Neu in Primary Gastric and Gastroesophageal Adenocarcinoma: An Experience from a Tertiary Center in South India
by: Aditi Damle, et al.

Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?—A Prospective Institution-Based Study
by: Susnata Khan, et al.
Published: (2024-10-01)

乳腺癌病人血清HER-2/neu检测及其临床意义
by: 朱美琴, et al.
Published: (2007-01-01)

Expression and clinical significance of HER2/neu, aromatase P450 and adhesion molecule CD24 in endometrial cancer
by: Liyun Guan, et al.
Published: (2023-08-01)

Combined Expression of HGFR with Her2/neu, EGFR, IGF1R, Mucin-1 and Integrin α2β1 Is Associated with Aggressive Epithelial Ovarian Cancer
by: Bastian Czogalla, et al.
Published: (2022-10-01)

Utilizing immune signatures for breast cancer subtyping in treatment approaches
by: Nguyen Thi Giang An
Published: (2023-06-01)

A clinico-immunohistopathological study of urothelial neoplasms with an expression of HER2/Neu and Ki-67 in malignant lesions presenting to a tertiary centre
by: Fatima Rasheed, et al.
Published: (2023-09-01)

Chemotherapeutic Activity of Imidazolium-Supported Pd(II) <i>o</i>-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells
by: Aeshah A. Awaji, et al.
Published: (2023-12-01)

Association of hormone receptors and human epidermal growth factor receptor-2/neu expressions with clinicopathologic factors of breast carcinoma: a cross-sectional study in a tertiary care hospital, Kabul, Afghanistan
by: Esmatullah Esmat, et al.
Published: (2024-03-01)

Breast Cancer in Mosul: A Survival Analysis
by: Taha HT Al-Saigh, et al.
Published: (2020-06-01)

The susceptibility to infection by Leishmania panamensis and the sensitivity to drugs differ according to the macrophage type Expresión de los receptores hormonales (RE/RP) y sobreexpresión de la proteína HER-2/neu en carcinoma ductal infiltrante
by: Olga T. Anteliz B., et al.
Published: (2011-08-01)

Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2/neu Expression Patterns in Gastric Cancer, and Their Association with One Year Survival in North-West of Iran
by: Zohreh Sanaat, et al.
Published: (2013-09-01)

Immunohistochemical Analysis of p53, Ki-67, CD44, HER-2/neu Expression Patterns in Gastric Cancer, and their Association with one-year Survival in North-West of Iran
by: Zohreh Sanaat, et al.
Published: (2013-07-01)

A case of pathological complete regression in combined modality treatment of resectable Her2/neu-positive gastric cancer
by: A. V. Avgustinovich, et al.
Published: (2024-03-01)